Condition
Pancreatic Cancer Metastatic to Liver clinical trials and research
Research outlook What's coming for Pancreatic cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 Pancreatic Cancer Metastatic to Liver clinical trials that are recruiting, at sites in 2 countries (most in Sweden (1), China (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Palliative ERCP and RFA ablation for metastatic, inoperable pancreatic tumors
This trial tests whether combining ERCP-guided Habib EndoHPB RFA with palliative chemotherapy can help patients with metastatic pancreatic cancer to the liver.
-
Combining adebelimab with chemotherapy for treating liver metastasis from pancreatic cancer
This study is testing if combining a new drug called adebelimab with standard chemotherapy can help people with pancreatic cancer that has spread to the liver feel better and improve their treatment results.
Quick answers
How many Pancreatic Cancer Metastatic to Liver clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Sweden (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.